Clinical trial
Trial of PI-88 With Docetaxel in Advanced Non-Small-Cell Lung Cancer (NSCLC)
NCT00097851 · Cellxpert Biotechnology Corp., Industry · Completed
Key facts
| NCT number | NCT00097851 |
|---|---|
| Title | Trial of PI-88 With Docetaxel in Advanced Non-Small-Cell Lung Cancer (NSCLC) |
| Official title | Phase II Trial of Docetaxel With PI-88 in Patients With Advanced Non-Small-Cell Lung Cancer |
| Lead sponsor | Cellxpert Biotechnology Corp., Industry |
| Collaborators | Medigen Biotechnology Corporation Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Non-Small-Cell Lung |
| Intervention type | Drug |
| Interventions | docetaxel, PI-88 |
| Enrollment | 100 |
| Start date | Feb 1, 2004 |
| Completion | Jul 1, 2006 |
| First posted | Dec 1, 2004 |
| Last update posted | Jun 27, 2022 |
| Countries | Australia |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: